Anti-tumor effects of interleukin-2 and
✍
F. Belardelli; V. Ciolli; U. Testa; E. Montesoro; D. Bulgarinl; E. Proietti; P.
📂
Article
📅
1989
🏛
John Wiley and Sons
🌐
French
⚖ 965 KB
We have studied the anti-tumor effects of human recombinant IL2, alone or in association with LAKcells, in mice transplanted subcutaneously (s.c.) with the following syngeneic tumors: highly metastatic Friend leukemia cells (FLC), nonmetastatic FLC, lymphoma RBL-5 cells and HeJ16 fibrosarcoma cells.